2invest AG (FRA:2INV)
Germany · Delayed Price · Currency is EUR 7.68
0.00 (0.00%)
At close: Oct 28, 2026
2invest AG Market Cap
2invest AG has a market cap or net worth of €42.21 million as of October 28, 2026. It is the 30,502nd most valuable company in the world and the 411th biggest in Germany. Its market cap has decreased by 40.19% in one year.
Market Cap
42.21M
Enterprise Value
33.68M
Revenue
n/a
Global Rank
Country Rank
#411 Germany
PE Ratio
n/a
ChartMarket Cap Chart
Since December 7, 2012, 2invest AG's market cap has increased from 35.90M to 42.21M, an increase of 17.58%. That is a compound annual growth rate of 1.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 42.21M | -32.85% |
| Dec 30, 2025 | 62.87M | -5.72% |
| Dec 30, 2024 | 66.68M | 65.71% |
| Dec 29, 2023 | 40.24M | -19.72% |
| Dec 30, 2022 | 50.12M | -32.92% |
| Dec 30, 2021 | 74.73M | -18.39% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 78.00M |
| Biomark Diagnostics | 29.60M |
| Vidac Pharma Holding | 21.42M |
| Paion AG | 328.15K |
| bioXXmed AG | 259.63K |
| co.don AG | 187.06K |
| MagForce AG | 91.72K |